Product/Service

Comprehensive Analytical Methods

Source: Covance Laboratories, Inc.
Covance provides a comprehensive and growing list of analytical methods supporting small and large molecule development from our six-site global network of bioanalytical resources.

Covance provides a comprehensive and growing list of analytical methods supporting both small and large molecule development from our six-site global network of flexible bioanalytical resources. We enhance the drug development experience by bringing world class service, scientific expertise and efficiency to every client study.

Small Molecule Services

Dried Blood Spot (DBS) Integrated Toxicology & Bioanalytical Services
Covance is the first CRO to bring regulatory toxicology and bioanalytical support (nonclinical and clinical) to the global market using the Dried Blood Spot (DBS) TK/PK sampling technique. The DBS technique offers the following benefits:

  • Up to 50% reduction in the number of rodents required per study
  • 60-85% reduction in blood volume requirements
  • Refined sampling technique
  • Improved quality of TK profile data
  • Increased flexibility in clinical trial design
  • Reduced hazards in sample handling
  • Reduced shipping cost
  • Enhanced compound stability

Learn more about how DBS can benefit your next study.

View our poster on Dried Blood Spot applications focusing on enhancing assay sensitivity.

Quantitative Peptide Analysis by LC-MS/MS
Dedicated team demonstrates improved turnaround time, consistency and robustness in the analysis of biologics. Find out more about our three-tiered approach using mass spectrometry.

Covance Streamlines Clinical Bioanalysis of 35,000 Phase III Samples
Find out about we helped our client meet NDA filing deadline, processing over 35,000 samples simultaneously in Europe and North America. Click here to read the case study.

Covance Appoints Dr. Douglas M. Fast to Head Global Bioanalytical Services
New bioanalytical expert brings more than 16 years of industry, regulatory experience to help biopharmaceutical companies speed drug development.

Large Molecule Services

Assessment of Biopharmaceutical Drug's Immunogenic Potential
Biopharmaceuticals account for nearly 33% of all drugs in development, and while they hold great promise, immunogenicity concerns require appropriate analysis. Learn more about Covance's approach to immunogenicity assessment.

40% Cost Savings Via Optimized Assay Program
Covance optimized assays and validated new methods to GLP standards, saving the client significant time and costs. View the complete case study here.

Covance Increase Efficiency Over 55% to Meet Aggressive Deadline
Covance drives efficiencies to make up for time delays in completing pivotal IND enabling study. Read the complete story here.

Covance Appoints Dr. John Q. Kamerud to Immunochemistry Services
New bioanalytical expert brings over 10 years of industry experience to his new role as Associate Director.

Comprehensive Methods List
Learn more about our complete list of methods here.

Dedicated Resource Agreements Deliver Cost Savings
Many pharmaceutical companies are choosing to outsource drug development services with CROs to bring better focus and cost savings to their organizations. Learn more in our informative white paper.